Sleep Interventions for Sleep Disorders
Trial Summary
What is the purpose of this trial?
This protocol focuses on the effect of sleep interventions on improving sleep and building cognitive/brain resilience in older adults with amnestic mild cognitive impairment and sleep disturbance. Two sleep interventions, cognitive behavioral therapy for insomnia (CBTI) and acoustic slow-wave activity enhancement (SWAE), will be utilized in a pilot randomized clinical trial in which participants are randomized to different treatment groups (CBTI or SWAE). Participants will be assessed over a 6-month period in order to examine the impact of sleep treatments on neuropsychological outcomes and cognitively mediated everyday functioning.
Will I have to stop taking my current medications?
If you take sleep medications more than 3 times a week, you cannot join the study. If you take them 3 or fewer times a week, you'll need to stop before the study starts, but this will be done with your doctor's guidance to ensure safety.
What data supports the effectiveness of the treatment Acoustic Slow-Wave Activity Enhancement, Cognitive Behavioral Therapy for Insomnia, CBT-I, Digital CBT-I, dCBT-I for sleep disorders?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I) is as effective as sleep medications in the short term and more effective in the long term for improving sleep quality. Digital CBT-I (dCBT-I) has also been found to significantly improve sleep duration, reduce the time it takes to fall asleep, and enhance overall sleep efficiency.12345
Is digital cognitive behavioral therapy for insomnia safe for humans?
How is the treatment Acoustic Slow-Wave Activity Enhancement and Cognitive Behavioral Therapy for Insomnia (CBT-I) different from other treatments for sleep disorders?
This treatment is unique because it combines Acoustic Slow-Wave Activity Enhancement, which uses sound to improve deep sleep, with Cognitive Behavioral Therapy for Insomnia (CBT-I), a non-drug approach that addresses the thoughts and behaviors affecting sleep. Unlike medications, CBT-I has long-term benefits and can be delivered digitally, making it more accessible.17101112
Research Team
Hyun Kim, PhD
Principal Investigator
Columbia University/ New York State Psychiatric Institute
Eligibility Criteria
This trial is for English-speaking adults aged 60-85 with mild cognitive impairment and sleep disturbances. They must score at least 22 on a memory screening, have internet access, and an informant to participate. Excluded are those with certain neurological diseases, untreated diabetes, active cancer treatment, other sleep disorders besides insomnia, severe psychiatric conditions or depression.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either cognitive behavioral therapy for insomnia (CBTI) or acoustic slow-wave activity enhancement (SWAE) over 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Acoustic Slow-Wave Activity Enhancement
- Cognitive Behavioral Therapy for Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York State Psychiatric Institute
Lead Sponsor
Columbia University
Collaborator